Send to:

Choose Destination
See comment in PubMed Commons below
Expert Rev Pharmacoecon Outcomes Res. 2002 Dec;2(6):597-606. doi: 10.1586/14737167.2.6.597.

Treatment satisfaction as an outcome measure in cancer clinical treatment trials.

Author information

  • 1Institut Curie, Psycho-Oncology Unit, 26, rue d'Ulm, F - 75231 Paris Cedex 05 France.


For many years, medical research has focused on 'hard' end-points, such as survival or time to progression, when evaluating research in cancer clinical trials. However, over recent years more recognition has been given to 'softer' end-points, such as quality of life and treatment satisfaction. In many respects, research into treatment satisfaction is in its early stages of development, but we are already beginning to understand that patients' treatment satisfaction can provide great insights into the management of cancer patients. In our review, we discuss the specific conceptual and methodological issues we face when assessing treatment satisfaction in cancer clinical trials and critically review earlier studies of cancer treatment satisfaction.

PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Informa Healthcare
    Loading ...
    Write to the Help Desk